期刊文献+

低剂量纳洛酮对曲马多镇痛效应的影响 被引量:3

The effect of low-dose naloxone on analgesia of tramadol
下载PDF
导出
摘要 目的探讨低剂量的纳洛酮对曲马多镇痛效应的影响。方法择期在全麻下行经腹全子宫切除术患者80例,随机分为4组,所有的患者在手术结束前30min静脉注射2mg/kg曲马多负荷量,术后行患者自控静脉镇痛(PCIA)。镇痛药物选择曲马多20mg/kg,Ⅰ组不用纳洛酮(n=20),Ⅱ组纳洛酮2.4μg/kg(n=20),Ⅲ组纳洛酮4.8μg/kg(n=20),Ⅳ纳洛酮9.6μg/kg(n=20),稀释成100ml。PCA泵输注速度2ml/h,锁定时间15min。通过双盲方法分别于使用PCIA后1、6、12、24h使用视觉模拟评分(VAS)评估疼痛评分,记录恶心、呕吐评分、镇静评分、不良反应等。结果 75例患者参与这项研究,这些患者中曲马多静脉镇痛均提供了满意的镇痛效果。与对照组比较,纳洛酮组VAS评分差异无统计学意义,Ⅱ、Ⅲ、Ⅳ组在6h、12h和24h的镇静评分更低,P<0.05,恶心、呕吐评分在1、6、12、24h较对照组更低,P<0.05。而不同剂量纳洛酮组之间差异无统计学意义。结论低剂量的纳洛酮可以缓解曲马多引起的不良反应,而对其镇痛效应影响不明显。 Objective To explore the effect of low-dose naloxone on analgesia of tramadol.Methods Eighty patients undergoing general anesthesia for elective total abdominal hysterectomy were randomly divided into four groups.All patients received 2mg/kg tramadol 30 minutes before the end of surgery,followed by a continuous infusion with 20mg/kg tramadol with no naloxone(groupⅠn=20),2.4μg/kg naloxone(groupⅡn=20),4.8μg/kg naloxone(group Ⅲ n=20),9.6μg/kg(group Ⅳ n=20),diluted to 100ml.Pain assessments were recorded one hour after starting the PCIA and then at 6、12 and 24 hours by using visual analogue scale(VAS).Nausea Vomiting score,sedation score and side effect were also recorded.Results Seventy-five patients were included in this study.The intravenous tramadol administration provided the satisfied analgesia.There was no significant difference in VAS scores among naloxone groups and control group,compared with control group,sedation was less in group Ⅱ Ⅲ and Ⅳ at 6,12 and 24 hours,P〈0.05.The incidence of nausea vomiting in the naloxone group was lower than control group,P〈0.05.Conclusion A small-dose naloxone infusion could reduce tramadol induced side effects without reversing its analgesia effects.
出处 《四川医学》 CAS 2012年第7期1169-1171,共3页 Sichuan Medical Journal
关键词 纳洛酮 曲马多 低剂量 镇痛 naloxone tramodal low-dose analgesia
  • 相关文献

参考文献7

  • 1Sartain JB,Barry JJ,Richardson CA,et al.Effect of combining nal-oxone and morphine for intravenous patient-controlled analgesia[J].Anesthesiology,2003,99(1):148~151.
  • 2Shamin F,Hoda MQ,Samad K,et al.Comparison between tramadol and pethidine in patient controlled intravenous analgesia[J].Pak Med Assoc Oct,2006,56(10):433~436.
  • 3Kitahara M,Kojima K,Hanada M,et al.Effectiveness of oral tramadol hydrochloride for chronic non-malignant pain[J].Masui,2009,58(8):971 -975.
  • 4姚鹏,孟凌新,崔健君.阿片受体激动药伍用小剂量拮抗药用于镇痛的研究进展[J].国外医学(麻醉学与复苏分册),2004,25(2):80-83. 被引量:33
  • 5Crain SM,KF Shen.Antagonists of excitatory opioid receptor functions enhance morphine' s analgesic potency and attenuate opioid tolerance/ dependence liability[J].Pain,2000,84(2 -3):121-131.
  • 6Crain SM,KF Shen.Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naive mice pretreated briefly with GMI ganglioside or in chronic morphine-dependent mice[J].Brain Res,2007,1167:31 -41.
  • 7Crain SM,KF Shen.Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naive mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone[J].Brain Res,2008,1231:16~24.

二级参考文献25

  • 1Shen KF, Crain SM. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence. Brain Res,2001,919(1) :20-30.
  • 2Yang W, Law PY, Guo X, et al. In vivo activation of a mutant mu-opioid receptor by antagonist: Future direction for opiate pain treatment paradigm that lacks undesirable side effects. Proc Natl Acad Sci USA, 2003, 100(4): 2117-2121.
  • 3Mehlisch DR. The combination of low dose of naloxone and morphine in patient-controlled (PCA) does not decrease opioid requirements in the postoperative period. Pain, 2003,101 (1-2) :209-211.
  • 4Sartain JB, Barry JJ, Richardson CA, et al. Effect of combining naloxone and morphine for intravenous patient-controlled analgesia. Anesthesiology,2003,99( 1 ): 148-151.
  • 5Gear RW, Cordon NC, Miaskowski C, et al. Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans.Neurosci Lett, 2003,351 (1):5-8.
  • 6Ammer H, Christ TE. Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity.J Neurochem,2002,83(4) :818-827.
  • 7Ono T, Inoue M, Rashid MH, et al. Stimulation of peripheral nociceptor endings by low dose morphine and its signaling mechanism. Nenrochem Int,2002,41 (6) :399-407.
  • 8Lee J, Shim JY, Choi JH, et al. Epidural naloxone reduces intestinal hypomotility but not analgesia of epidural morphine. Can J Anaesth,2001,48(1) :54-58.
  • 9Choi JH, Lee J, Choi JH, et al. Epidural naloxone reduces pruritus and nausea without affecting analgesia by epidural morphine in bupivacaine.Can J Anaesth,2000,47(1) :33-37.
  • 10Shen J, Benedict Comes A, Gallagher A, et al. Bole of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice. Synapse,2000,38(3):322-327.

共引文献32

同被引文献16

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部